Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAib Group Regulatory News (AIBG)

Share Price Information for Aib Group (AIBG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 433.00
Bid: 434.50
Ask: 438.50
Change: 5.00 (1.17%)
Spread: 4.00 (0.921%)
Open: 426.00
High: 436.50
Low: 426.00
Prev. Close: 428.00
AIBG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Findel plc

18 Mar 2019 07:00

RNS Number : 0947T
AIB Group PLC
18 March 2019
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

AIB Group plc and its subsidiaries

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

AIB Venture Capital Limited

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Findel plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

17th March 2019

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

Convertible Shares 23.97

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

9,962,594

5.96%

(2) Cash-settled derivatives:

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

9,962,594

5.96%

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

None

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

18th March 2019

Contact name:

Terence Liston

Telephone number*:

+353 16419313

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETLLFVTVTIDLIA
Date   Source Headline
26th Jan 20227:06 amRNSAIB Group plc - SREP
20th Jan 20229:00 amRNSNotification of Major Holdings
21st Dec 20217:13 amRNSAIB - State's intention to sell part shareholding
21st Dec 20217:00 amRNSIntention to sell shares in AIB Group Plc
25th Nov 20219:00 amRNSChange in Director Details
23rd Nov 20217:00 amRNSAIB announces sale of SME portfolio in GB
3rd Nov 20217:00 amRNSAIB Group plc - Q3 2021 Trading Update
28th Oct 20219:30 amRNSAppointment of Chair
14th Oct 20215:11 pmRNSAIB - sale of non-performing loan portfolio
5th Oct 202110:00 amRNSAIB confirms date for Q3 2021 Trading Update
14th Sep 202111:00 amRNSAppointment of Directors
1st Sep 20217:00 amRNSAIB - acquisition of Goodbody completion
6th Aug 202112:30 pmRNSNotification of Transaction by PDMR and PCA
4th Aug 20217:00 amRNSAIB - Half-Yearly Financial Results 2021
30th Jul 20215:28 pmRNSAIB Group plc – EBA European-Wide Stress Test 2021
30th Jun 20213:00 pmRNSAIB Group confirms date for HY21 Financial Results
28th Jun 20217:02 amRNSAIB acquisition of EUR4.2bn Ulster Bank loans
25th Jun 202111:00 amRNSNotification of Major Holdings
23rd Jun 20215:36 pmRNSAIB forms JV with Great-West Lifeco
18th Jun 202110:00 amRNSAppointment of Director
28th May 202111:00 amRNSAppointment of Executive Director
11th May 202112:00 pmRNSStabilisation Notice
10th May 20218:26 amRNSStabilisation Notice
6th May 20213:30 pmRNSResults of AGM 2021
6th May 20217:00 amRNSAIB Group plc Q1 2021 Trading Update
20th Apr 20211:04 pmRNSAIB confirms date for Q1 2021 Trading Update
1st Apr 20213:00 pmRNSNotice of Annual General Meeting 2021
29th Mar 202112:00 pmRNSChange in Director Details
16th Mar 20214:45 pmRNSChange in Director Details
15th Mar 20213:00 pmRNSAppointment of Director
11th Mar 202111:00 amRNSUpdate on Migration from CREST to Euroclear Bank
10th Mar 20219:30 amRNSNotification of Transaction by PDMR
8th Mar 202110:20 amRNSNotification of Transaction by PDMR
5th Mar 20217:00 amRNSAIB Group plc - 2020 Annual Financial Results
2nd Mar 20212:00 pmRNSAIB Group plc - Acquisition of Goodbody
19th Feb 20217:12 amRNSAIB – Sale of non-performing loan portfolio
19th Feb 20217:10 amRNSAIB-potential acq Ulster Bk's Corp & Comm loan bk
5th Feb 202112:00 pmRNSResults of Extraordinary General Meeting
22nd Jan 202110:00 amRNSAppointment of Director
14th Jan 202110:00 amRNSNotice of Results - AIB to publish on 5 March 2021
11th Jan 20213:00 pmRNSNotice of Extraordinary General Meeting
30th Dec 20207:00 amRNSAIB Group plc - Currency Change on LSE
22nd Dec 202012:30 pmRNSForm 8.3 - Studio Retail Group plc
8th Dec 20202:52 pmRNSNotification of Major Holdings
2nd Dec 20207:00 amRNSAIB Group plc Medium-Term Targets
5th Nov 20207:00 amRNSDirectorate Change
30th Oct 20207:00 amRNSTrading Statement
7th Oct 202012:39 pmRNSAIB announces date for Q3 2020 Trading Update
2nd Oct 20201:29 pmRNSStabilisation Notice
23rd Sep 202010:28 amRNSStabilisation Notice

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.